Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

L Platt, S Minozzi, J Reed, P Vickerman… - Cochrane Database …, 2017 - cochranelibrary.com
Needle syringe programmes and opioid substitution therapy for preventing hepatitis C
transmission in people who inject drugs - Platt, L - 2017 | Cochrane Library Skip to Content …

The opioid crisis and HIV in the USA: deadly synergies

SL Hodder, J Feinberg, SA Strathdee, S Shoptaw… - The Lancet, 2021 - thelancet.com
The opioid epidemic is one of the greatest public health problems that the USA faces. Opioid
overdose death rates have increased steadily for more than a decade and doubled in 2013 …

[HTML][HTML] Incidence of HIV and hepatitis C virus among people who inject drugs, and associations with age and sex or gender: a global systematic review and meta …

A Artenie, J Stone, H Fraser, D Stewart… - The lancet …, 2023 - thelancet.com
Background Measuring the incidence of HIV and hepatitis C virus (HCV) infection among
people who inject drugs (PWID) is key to track progress towards elimination. We aimed to …

Sex disparities in presentation and prognosis of 1110 patients with hepatocellular carcinoma

NE Rich, CC Murphy, AC Yopp, J Tiro… - Alimentary …, 2020 - Wiley Online Library
Background Although sex disparities in hepatocellular carcinoma (HCC) incidence have
been well described, there are limited data examining sex disparities in HCC prognosis. Aim …

Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia

J Iversen, GJ Dore, B Catlett, P Cunningham… - Journal of …, 2019 - Elsevier
Background & Aims The World Health Organization (WHO) established targets to eliminate
hepatitis C virus (HCV) infection as a public health threat by 2030. Evidence that HCV …

[HTML][HTML] Management of acute HCV infection in the era of direct-acting antiviral therapy

M Martinello, B Hajarizadeh, J Grebely… - Nature reviews …, 2018 - nature.com
The management of acute HCV infection has not been standardized following the
availability of direct-acting antiviral agents (DAAs) for chronic HCV infection, and substantial …

[HTML][HTML] Rapid hepatitis C virus point-of-care RNA testing and treatment at an integrated supervised consumption service in Toronto, Canada: a prospective …

B Lettner, K Mason, ZR Greenwald, J Broad… - The Lancet Regional …, 2023 - thelancet.com
Background Despite high burden of Hepatitis C (HCV) among people who inject drugs,
significant barriers to care persist. The aim of this study was to evaluate the provision of …

[HTML][HTML] Epidemiology and elimination of HCV-related liver disease

P Pradat, V Virlogeux, E Trépo - Viruses, 2018 - mdpi.com
Hepatitis C virus (HCV) infection, defined by active carriage of HCV RNA, affects nearly
1.0% of the worldwide population. The main risk factors include unsafe injection drug use …

[HTML][HTML] Acute hepatitis C virus infection: clinical update and remaining challenges

CH Liu, JH Kao - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
Acute hepatitis C virus (HCV) infection is a global health concern with substantial
geographical variation in the incidence rate. People who have received unsafe medical …

Prevalence, estimated incidence, risk behaviours, and genotypic distribution of hepatitis C virus among people who inject drugs accessing harm-reduction services in …

MJ Akiyama, CM Cleland, JA Lizcano… - The Lancet Infectious …, 2019 - thelancet.com
Summary Background Sub-Saharan Africa has a large population of people with hepatitis C
virus (HCV) infection, yet little is known about HCV among people who inject drugs this …